|
|
||||||||
B Essential Modifier-Binding Domain Peptides in the Adoptive Transfer Model of Experimental Allergic Encephalomyelitis1


* Section of Neuroscience, Department of Oral Biology, University of Nebraska Medical Center, Lincoln, NE 68583;
Center for Biotechnology, University of Nebraska, Lincoln, NE 68588; and
Section of Immunobiology and Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT 06536
It has been shown that peptides corresponding to the NF-
B essential modifier-binding domain (NBD) of I
B kinase
or I
B kinase
specifically inhibit the induction of NF-
B activation without inhibiting the basal NF-
B activity. The present study demonstrates the effectiveness of NBD peptides in inhibiting the disease process in adoptively transferred experimental allergic encephalomyelitis (EAE), an animal model of multiple sclerosis. Clinical symptoms of EAE were much lower in mice receiving wild-type (wt)NBD peptides compared with those receiving mutated (m)NBD peptides. Histological and immunocytochemical analysis showed that wtNBD peptides inhibited EAE-induced spinal cord mononuclear cell invasion and normalized p65 (the RelA subunit of NF-
B) expression within the spinal cord. Analysis of lymph node cells isolated from donor and recipient mice showed that wtNBD peptides but not mNBD peptides were able to shift the immune response from a Th1 to a Th2 profile. Consistently, wtNBD peptides but not mNBD peptides inhibited the encephalitogenicity of myelin basic protein-specific T cells. Furthermore, i.p. injection of wtNBD peptides but not mNBD peptides was also able to reduce LPS- and IFN-
-induced expression of inducible NO synthase, IL-1
, and TNF-
in vivo in the cerebellum. Taken together, our results support the conclusion that NBD peptides are antineuroinflammatory, and that NBD peptides may have therapeutic effect in neuroinflammatory disorders such as multiple sclerosis.
This article has been cited by other articles:
![]() |
S. H. Dave, J. S. Tilstra, K. Matsuoka, F. Li, T. Karrasch, J. K. Uno, A. R. Sepulveda, C. Jobin, A. S. Baldwin, P. D. Robbins, et al. Amelioration of Chronic Murine Colitis by Peptide-Mediated Transduction of the I{kappa}B Kinase Inhibitor NEMO Binding Domain Peptide J. Immunol., December 1, 2007; 179(11): 7852 - 7859. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ghosh, A. Roy, X. Liu, J. H. Kordower, E. J. Mufson, D. M. Hartley, S. Ghosh, R. L. Mosley, H. E. Gendelman, and K. Pahan Selective inhibition of NF-{kappa}B activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease PNAS, November 20, 2007; 104(47): 18754 - 18759. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roy, X. Liu, and K. Pahan Myelin Basic Protein-primed T Cells Induce Neurotrophins in Glial Cells via {alpha}5beta3 Integrin J. Biol. Chem., November 2, 2007; 282(44): 32222 - 32232. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dasgupta, A. Roy, M. Jana, D. M. Hartley, and K. Pahan Gemfibrozil Ameliorates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Independent of Peroxisome Proliferator-Activated Receptor-{alpha} Mol. Pharmacol., October 1, 2007; 72(4): 934 - 946. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jana, A. Jana, X. Liu, S. Ghosh, and K. Pahan Involvement of Phosphatidylinositol 3-Kinase-Mediated Up-Regulation of I{kappa}B{alpha} in Anti-Inflammatory Effect of Gemfibrozil in Microglia J. Immunol., September 15, 2007; 179(6): 4142 - 4152. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Greve, R. Weissert, N. Hamdi, E. Bettelli, R. A. Sobel, A. Coyle, V. K. Kuchroo, K. Rajewsky, and M. Schmidt-Supprian I{kappa}B Kinase 2/beta Deficiency Controls Expansion of Autoreactive T Cells and Suppresses Experimental Autoimmune Encephalomyelitis J. Immunol., July 1, 2007; 179(1): 179 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brahmachari and K. Pahan Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Modifies T Cells at Multiple Steps and Inhibits Adoptive Transfer of Experimental Allergic Encephalomyelitis J. Immunol., July 1, 2007; 179(1): 275 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roy, Y. K. Fung, X. Liu, and K. Pahan Up-regulation of Microglial CD11b Expression by Nitric Oxide J. Biol. Chem., May 26, 2006; 281(21): 14971 - 14980. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brahmachari, Y. K. Fung, and K. Pahan Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J. Neurosci., May 3, 2006; 26(18): 4930 - 4939. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jana and K. Pahan Fibrillar Amyloid-{beta} Peptides Kill Human Primary Neurons via NADPH Oxidase-mediated Activation of Neutral Sphingomyelinase: IMPLICATIONS FOR ALZHEIMER'S DISEASE J. Biol. Chem., December 3, 2004; 279(49): 51451 - 51459. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |